Skip to main content
. 2023 Nov 30;7(6):zrad106. doi: 10.1093/bjsopen/zrad106

Table 1.

Demographic, preoperative, operative and postoperative details

Total no. of patients included 1348
Age (years), mean (s.d.) 66.0 (9.8)
Female gender 587 (42.4)
BMI (kg/m2), mean (s.d.) 25.5 (4.4) Unknown/not recorded: 561 (40.5)
Preoperative co-morbidities
 Diabetes 277 (20.6) Unknown/not recorded: 38*
 Cardiovascular 590 (42.6)
 Respiratory 142 (10.5)
Preoperative biliary stent 875 (63.3) Unknown/not recorded: 2*
Neoadjuvant chemotherapy received 61 (4.6)
Preoperative blood tests, median (i.q.r.)
 Bilirubin (µmol/l) 42 (10-52) Unknown/not recorded: 2 (0.1)
 Albumin (g/l) 10 (32-42) Unknown/not recorded: 100 (7.4)
 Neutrophils (×109/l) 2.8 (3.7-6.5) Unknown/not recorded: 28 (2.1)
 Lymphocytes (×109/l) 1.2 (1.3-2.5) Unknown/not recorded: 28 (2.1)
ASA grade > II 467 (33.7) Unknown/not recorded: 116*
Positive nodes on preoperative CT 324 (27.7) Unknown/not recorded: 177*
Type of PD performed Classic Whipple: 660 (49.1)
Pylorus-preserving PD: 685 (50.9)
Unknown/not recorded: 3*
Pancreatic anastomosis P-J: 1064 (81.2)
P-G: 246 (18.8)
Unknown/not recorded: 38*
Concomitant venous resection 205 (15.5) Unknown/not recorded: 28*
Concomitant arterial resection 25 (1.9) Unknown/not recorded: 29*
Intraoperative blood transfusion 164 (18.1) Unknown/not recorded: 442*
Unplanned return to theatre 74 (5.5)
Length of stay (days), median (i.q.r.) 10 (10-20) Unknown/not recorded: 70 (5.2)
30-day unplanned readmission 134 (10.0) Unknown/not recorded: 5 (0.4)
90-day mortality 51 (4.0)
Postoperative histology
 PDAC 792 (58.8)
 AA 364 (27.0)
 CC 192 (14.2)

Values are n (%) unless otherwise indicated. AA, ampullary adenocarcinoma; CC, cholangiocarcinoma; CT, computed tomography; HDU, high dependency unit; PD, pancreatoduodenectomy; PDAC, pancreatic ductal adenocarcinoma; P-G, pancreato-gastrostomy; P-J, pancreato-jejunostomy. *Not included in percentages.